Not one Misdraw to blame for the failure of import substitution drugs, experts say

© RIA Novosti / Michael Voskresenskiye in fotomekhanicheskim manufacture. Archival photoNot one Misdraw to blame for the failure of import substitution drugs, experts say© RIA Novosti / Michael Voskresenskiye the image Bank

You can not blame only the Ministry of health in the failure of import substitution of drugs, according to respondents RIA Novosti experts.

Earlier, the speaker of the state Duma Vyacheslav Volodin has declared that the Ministry of health has not fulfilled effectively work on import substitution of medicines in the Russian market, 68% of the market is an import, while US companies get a net profit of approximately $ 50 billion per year.

«The Ministry is not acting alone, and together with the Federal Antimonopoly service. The Ministry of health we have a lot of stuff to do and many have done more, but to accuse him of import substitution I can not» — said the President of League of defenders of patients Alexander Saversky.

Nikolay Dronov, Chairman of the Executive Committee of the interregional public movement «Movement against cancer», also believes that blaming only the Ministry of health in the failure of import substitution wrong.

«The Ministry of health the tasks confronted, I think, has accomplished, just the task of import substitution is a function not only of the Ministry of health, but also the industry and trade Ministry and the whole government. This work is carried out. It is difficult to assess the pace, but with the appearing on the market to our counterparts, generic drugs, for example, antitumor, this work is carried out, it is far advanced,» — said the drones.

He added that, while performing import substitution of drugs 100% failed.

«I’m insecure look at what sanctions against the US will lead to major danger to the lives of patients, because it is not such a huge amount of drugs imported is from the United States,» — said the drones.

Source